Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B‐ and T‐cell acute lymphoblastic leukemia

Abstract Here, we report the results of the prospective cohort study EORTC‐CLG 58081 and compare them to the control arm of the randomized phase 3 trial EORTC‐CLG 58951, on which treatment recommendations were built. In both studies, patients aged 1–18 years with BCR::ABL1 negative acute lymphoblast...

詳細記述

書誌詳細

主要な著者:	Carine Domenech, Michal Kicinski, Barbara De Moerloose, Caroline Piette, Wadih A. Chahla, Laure Kornreich, Marlène Pasquet, Anne Uyttebroeck, Alexandre Theron, Marilyne Poirée, Chloé Arfeuille, Marleen Bakkus, Nathalie Grardel, Catherine Paillard, Claire Freycon, Frédéric Millot, Pauline Simon, Pierre Philippet, Claire Pluchart, Stefan Suciu, Pierre Rohrlich, Alina Ferster, Yves Bertrand, Hélène Cavé, for the Children's Leukemia Group (CLG) of the European Organization for Research and Treatment of Cancer (EORTC)
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2024-11-01
シリーズ:	HemaSphere
オンライン･アクセス:	https://doi.org/10.1002/hem3.70025
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!